Could a platelet booster help kids with bone marrow failure?
Disease control
Not yet recruiting
This phase II trial tests whether adding romiplostim, a drug that stimulates platelet production, to standard immunosuppressive therapy can improve blood cell counts in children and young adults with severe aplastic anemia. The study will enroll 15 participants aged 2 to 21 who a…
Phase: PHASE2 • Sponsor: Anjali Sharathkumar • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC